These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7875951)

  • 1. Serotonin and suicidality: the impact of acute fluoxetine administration. I: Serotonin and suicide.
    King RA; Segman RH; Anderson GM
    Isr J Psychiatry Relat Sci; 1994; 31(4):271-9. PubMed ID: 7875951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and suicidality: the impact of fluoxetine administration. II: Acute neurobiological effects.
    Anderson GM; Segman RH; King RA
    Isr J Psychiatry Relat Sci; 1995; 32(1):44-50. PubMed ID: 7622346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine-induced suicidality, serotonin, and seasonality.
    Brewerton TD
    Biol Psychiatry; 1991 Jul; 30(2):190-6. PubMed ID: 1912109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicide and antidepressants.
    Montgomery SA
    Drugs; 1992; 43 Suppl 2():24-30; discussion 30-1. PubMed ID: 1378370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.
    Giner L; Nichols CM; Zalsman G; Oquendo MA
    Int J Adolesc Med Health; 2005; 17(3):211-20. PubMed ID: 16231472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine and suicidal ideation.
    Ratan DA
    J Clin Psychopharmacol; 1997 Feb; 17(1):61-2. PubMed ID: 9004066
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    Baldwin D; Bullock T; Montgomery D; Montgomery S
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants and side effects.
    Grounds D; Stocky A; Evans P; Scott C; McIntosh R; Morrison E; Derham H; Yeatman R; Farnbach P
    Aust N Z J Psychiatry; 1995 Mar; 29(1):156-7. PubMed ID: 7625967
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).
    Hyttel J
    Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():19-26. PubMed ID: 8021435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H; Audenaert K; van Heeringen C
    Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine trial in suicidal depressed alcoholics.
    Cornelius JR; Salloum IM; Cornelius MD; Perel JM; Thase ME; Ehler JG; Mann JJ
    Psychopharmacol Bull; 1993; 29(2):195-9. PubMed ID: 8290665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
    Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
    Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors and violence: a review of the available evidence.
    Walsh MT; Dinan TG
    Acta Psychiatr Scand; 2001 Aug; 104(2):84-91. PubMed ID: 11473500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective serotonin reuptake inhibitors (SSRIs) on suicide: A network meta-analysis of double-blind randomized trials.
    Li Y; Chen C; Chen Q; Yuan S; Liang W; Zhu Y; Zhang B
    Psychiatry Res; 2024 Jun; 336():115917. PubMed ID: 38663222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.